Happy that the earnings guidance is reinforced.The acquisition sounds interesting to say the least.Happy to hold and I maintain, this is not a short term pick.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025